FDC of empagliflozin metformin is a diabetes medicine that contains two active substances called empagliflozin and metformin.
FDC of empagliflozin metformin is added to diet and exercise to treat type 2 diabetes in adult patients (aged 18 years and older) whose diabetes cannot be controlled by adding metformin alone or metformin with other medicines for diabetes.
FDC of empagliflozin metformin can also be combined with other medicines. These may be medicines taken by mouth or insulin given by injection.
In addition, FDC of empagliflozin metformin can be used as an alternative to taking both empagliflozin and metformin as single tablets. To avoid overdose, do not continue taking empagliflozin and metformin tablets separately, if you are taking this medicine.
It is important that you continue with your diet and exercise plan as told by your doctor, pharmacist or nurse.
Type 2 diabetes is a disease that comes from both your genes and your lifestyle. If you have type 2 diabetes, your pancreas does not make enough insulin to control the level of glucose in your blood, and your body is unable to use its own insulin effectively. This results in high levels of glucose in your blood which can lead to medical problems like heart disease, kidney disease, blindness, and poor circulation in your limbs.
What you need to know before you take FDC of empagliflozin metformin Do not take FDC of empagliflozin metformin:
Talk to your doctor, pharmacist or nurse before taking this medicine, and during treatment:
Due to the metformin component, FDC of empagliflozin metformin may cause a very rare, but very serious complication called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, prolonged fasting or alcohol intake, body fluid deficit (dehydration) due to severe diarrhoea or vomiting, liver problems and any medical conditions in which a region of the body is deprived with a lack of oxygen supply (such as acute severe heart diseases).
It is important to you to comply with your medication intake, dietary instructions and regular exercise program because this can reduce the risk of lactic acidosis.
The onset of lactic acidosis can be subtle and the symptoms can be non-specific such as vomiting, bellyache (abdominal pain) with muscle cramps, a general feeling of not being well with severe tiredness, and difficulty in breathing. Further symptoms are reduced body temperature and heart beat. If you experience some of these symptoms, you should seek immediately medical attention, as lactic acidosis may lead to coma. Stop taking FDC of empagliflozin metformin immediately and contact a doctor or the nearest hospital straight away.
Your kidneys will be tested by a blood test before you start taking and while you are taking this medicine.
Because of how this medicine works, your urine will test positive for sugar while you are taking this medicine.
This medicine is not recommended for use in children and adolescents under 18 years, because it has not been studied in these patients.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
It is important to tell your doctor if you are taking:
There is an increased risk of lactic acidosis following excessive alcohol consumption (particularly in the case of fasting, malnutrition, or liver disease). Therefore, avoid consumption of alcohol and medicines containing alcohol when taking FDC of empagliflozin metformin (see section 4, ‘Possible side effects’).
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take FDC of empagliflozin metformin if you are pregnant. It is unknown if this medicine is harmful to the unborn child.
Metformin passes into human milk in small amounts. It is not known whether empagliflozin passes into human breast milk. Do not take FDC of empagliflozin metformin if you are breast-feeding.
FDC of empagliflozin metformin has minor influence on the ability to drive and use machines.
Taking this medicine in combination with medicines called sulphonylureas or with insulin can cause blood sugar levels to drop too low (hypoglycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines. Do not drive or use any tools or machines if you feel dizzy while taking FDC of empagliflozin metformin.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The dose of FDC of empagliflozin metformin varies depending on your condition and the doses of diabetes medicines you currently take. Your doctor will adjust your dose as necessary and tell you exactly which strength of the medicine to take.
Diet and exercise can help your body use its blood sugar better. It is important to stay on the diet and exercise program recommended by your doctor while taking FDC of empagliflozin metformin.
If you take more FDC of empagliflozin metformin tablets than you should have, you may experience lactic acidosis. Symptoms of lactic acidosis are non-specific such as feeling or being very sick, vomiting, stomach ache with muscle cramps, a general feeling of not being well with severe tiredness, and difficulty in breathing. Further symptoms are reduced body temperature and heart beat. If this happens to you, you may need immediate hospital treatment, as lactic acidosis can lead to coma. Stop taking this medicine immediately and contact a doctor or the nearest hospital straight away. Take the medicine pack with you.
If you miss a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not take a double dose of this medicine.
Do not stop taking FDC of empagliflozin metformin without first consulting your doctor. Your blood sugar levels may increase when you stop taking FDC of empagliflozin metformin.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Lactic acidosis. Metformin, one of the active substances in this medicine, can cause a very rare (may affect up to 1 in 10,000 people) but serious side effect called ‘lactic acidosis’. This is a build-up of lactic acid in the blood that can cause death. Lactic acidosis is a medical emergency and must be treated in hospital. It particularly affects patients whose kidneys are not working properly.
Signs of ‘lactic acidosis’ are:
If this happens to you, you may need immediate hospital treatment, as lactic acidosis may lead to coma. Stop taking this medicine immediately and contact a doctor or the nearest hospital straight away. Take the medicine pack with you.
Contact a doctor or the nearest hospital straight away if you have any of the following side effects:
Diabetic ketoacidosis, seen rarely (may affect up to 1 in 1,000 people)
These are the signs of diabetic ketoacidosis (see also section 2, ‘Warnings and precautions’):
This may occur regardless of blood glucose level. Your doctor may decide to temporarily or permanently stop your treatment with FDC of empagliflozin metformin.
Contact your doctor as soon as possible if you notice the following side effects:
Low blood sugar (hypoglycaemia), seen very commonly (may affect more than 1 in 10 people) If you take FDC of empagliflozin metformin with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin, your risk of getting low blood sugar is increased. The signs of low blood sugar may include:
Your doctor will tell you how to treat low blood sugar levels and what to do if you get any of the signs above. If you have symptoms of low blood sugar, eat glucose tablets, a high sugar snack or drink fruit juice. Measure your blood sugar if possible and rest.
Urinary tract infection, seen commonly (may affect up to 1 in 10 people)
The signs of urinary tract infection are:
An urge to pass urine or more frequent urination may be due to the way FDC of empagliflozin metformin works, but as they can also be signs of urinary tract infection. If you note an increase in such symptoms, you should also contact your doctor.
Dehydration, seen uncommonly (may affect up to 1 in 100 people)
The signs of dehydration are not specific, but may include:
Other side effects while taking FDC of empagliflozin metformin:
Very common
Common
Uncommon
Very rare
If you get any side effects, talk to your doctor, pharmacist or nurse. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after ‘EXP’. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
If you have kidney disease, your healthcare provider will evaluate your condition to determine if empagliflozin/Sitagliptin is suitable for you.
Symptoms of infection may include painful urination, itching, or unusual discharge. Contact your doctor if you notice any of these signs for prompt treatment.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. In particular, you should tell your doctor if you are using the following medicines:
Yes, particularly in elderly patients or those on diuretics. Watch for symptoms like dizziness or fainting. Staying hydrated can help manage blood pressure while on empagliflozin
Some people may experience mild weight loss as empagliflozin helps remove excess glucose. Monitoring your weight can help track any unintended changes
It’s important to consult your doctor, as empagliflozin may need to be paused before surgery to reduce the risk of DKA. Follow their instructions closely
Empagliflozin/Sitagliptin is not approved for type 1 diabetes due to a higher risk of diabetic ketoacidosis. It’s only indicated for type 2 diabetes management
Your doctor may check your HbA1c every 3 to 6 months to monitor long-term glucose control. Regular self-monitoring of blood glucose may also be needed, especially if you’re adjusting doses
Contact your treating physician immediately and then stop taking Empagliflozin Sitagliptin as per his advise. Once you feel better, start taking Empagliflozin Sitagliptin as per his advise.
Contact your treating physician immediately and then stop taking Empagliflozin metformin as per his advise.